ORIGINAL RESEARCH article

Front. Microbiol., 26 September 2023

Sec. Food Microbiology

Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1275441

Effect of sublethal dose of chloramphenicol on biofilm formation and virulence in Vibrio parahaemolyticus

  • 1. Department of Clinical Laboratory, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China

  • 2. Physical Examination Center, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China

  • 3. School of Medicine, Nantong University, Nantong, China

Abstract

Vibrio parahaemolyticus isolates are generally very sensitive to chloramphenicol. However, it is usually necessary to transfer a plasmid carrying a chloramphenicol resistance gene into V. parahaemolyticus to investigate the function of a specific gene, and the effects of chloramphenicol on bacterial physiology have not been investigated. In this work, the effects of sublethal dose of chloramphenicol on V. parahaemolyticus were investigated by combined utilization of various phenotypic assays and RNA sequencing (RNA-seq). The results showed that the growth rate, biofilm formation capcity, c-di-GMP synthesis, motility, cytoxicity and adherence activity of V. parahaemolyticus were remarkably downregulated by the sublethal dose of chloramphenicol. The RNA-seq data revealed that the expression levels of 650 genes were significantly differentially expressed in the response to chloramphenicol stress, including antibiotic resistance genes, major virulence genes, biofilm-associated genes and putative regulatory genes. Majority of genes involved in the synthesis of polar flagellum, exopolysaccharide (EPS), mannose-sensitive haemagglutinin type IV pilus (MSHA), type III secretion systems (T3SS1 and T3SS2) and type VI secretion system 2 (T6SS2) were downregulated by the sublethal dose of chloramphenicol. Five putative c-di-GMP metabolism genes were significantly differentially expressed, which may be the reason for the decrease in intracellular c-di-GMP levels in the response of chloramphenicol stress. In addition, 23 genes encoding putative regulators were also significantly differentially expressed, suggesting that these regulators may be involved in the resistance of V. parahaemolyticus to chloramphenicol stress. This work helps us to understand how chloramphenicol effect on the physiology of V. parahaemolyticus.

Introduction

Vibrio parahaemolyticus (V. parahaemolyticus), the leading cause of seafood-related gastroenteritis, produces multiple virulence factors playing different roles in its pathogenesis, including thermostable direct hemolysin (TDH), TDH-related hemolysin (TRH), type III secretion systems (T3SS1 and T3SS2), type VI secretion systems (T6SS1 and T6SS2), lipopolysaccharide and extracellular proteases (Cai and Zhang, 2018; Osei-Adjei et al., 2018; Li et al., 2019; Pazhani et al., 2021). Both TDH and TRH have hemolytic activity, but only TDH can cause β-type hemolysis on Wagatsuma agar called the Kanagawa phenomenon (Xu et al., 1994; Cai and Zhang, 2018). TDH also possesses the lethal toxicity, cytotoxicity, and enterotoxicity (Park et al., 2004; Hiyoshi et al., 2010; Raghunath, 2014; Cai and Zhang, 2018). T3SS, a needle-like injection system, can manipulate host cell functioning by injecting toxic proteins into host cells (Pais et al., 2023). Both T3SS1 and T3SS2 are required for the full virulence of V. parahaemolyticus (Hiyoshi et al., 2010; Matsuda et al., 2012; Zhou et al., 2013; Gu et al., 2020; Hu et al., 2021; Lin et al., 2021). However, T3SS1 plays significant roles in cytotoxic activity against various cell lines and lethal activity in mice, whereas T3SS2 is the major contributor to enterotoxicity of V. parahaemolyticus (Hiyoshi et al., 2010). Moreover, T6SS1 possesses antibacterial activity and thus is required for the environmental fitness of V. parahaemolyticus, whereas T6SS2 plays a role in cell adhesion (Yu et al., 2012; Salomon et al., 2013; Coulthurst, 2019).

Vibrio parahaemolyticus is often found in the form of biofilms, which are matrix-enclosed, surface associated communities (Yildiz and Visick, 2009; Ruhal and Kataria, 2021). Some specific structures such as flagella, exopolysaccharide (EPS) and type IV pili are required for the mature biofilm formation of V. parahaemolyticus (Enos-Berlage et al., 2005; Shime-Hattori et al., 2006; Yildiz and Visick, 2009; Jung et al., 2019; Li et al., 2020; Ruhal and Kataria, 2021; Liu et al., 2022). V. parahaemolyticus expresses two kinds of flagellar systems, a polar flagellum for swimming in liquid and lateral flagella for swarming on the surface (McCarter, 2004). Loss of polar flagellum prevents V. parahaemolyticus to form mature biofilms (Enos-Berlage et al., 2005). The cpsA-K and scvA-O gene clusters are responsible for the synthesis of EPS in V. parahaemolyticus (Liu et al., 2022). Strains without cps genes form smooth colonies on the agar plate, whereas those without scv genes form wrinkly colonies (Liu et al., 2022). The wrinkly phenotype spreader has stronger biofilm formation capacities than the smooth phenotype strain (Wu et al., 2022). V. parahaemolyticus possesses two kinds of type IV pili, mannose-sensitive haemagglutinin type IV pili (MSHA) and chitin-regulated pili (ChiRP) (Shime-Hattori et al., 2006). MSHA is required for bacterial attachment, whereas ChiRP plays a role in bacterial agglutination (Shime-Hattori et al., 2006). V. parahaemolyticus biofilm formation is also strongly correlated with the contents of proteins and DNA in the extracellular polymeric substance (Li et al., 2020). In addition, some regulators such as QsvR (Zhang et al., 2019, 2023b), H-NS (Sun et al., 2014; Zhang et al., 2018; Xue et al., 2022) and ToxR (Chen et al., 2018; Zhang et al., 2018) and some regulatory processes such as quorum sensing (QS) pathways (Wang et al., 2013; Zhang et al., 2019; Liu et al., 2021; Zhang et al., 2023b) and cyclic di-GMP (c-di-GMP) (Kim and McCarter, 2007; Tamayo et al., 2007; Kimbrough et al., 2020; Kimbrough and McCarter, 2021; Zhong et al., 2022) are involved in the regulation of virulence and biofilm formation of V. parahaemolyticus.

Almost all V. parahaemolyticus isolates exhibited multiple antibiotics resistances, especially to ampicillin and colistin (Amalina et al., 2019; Mok et al., 2021; Sun et al., 2022; Zaafrane et al., 2022). Previously, two class 1 integrons, dfrA14-blaVEB-1-aadB and blaVEB-1-aadB-arr2-cmlA-blaOXA-10-aadA1, which are strongly associated with the resistance to multiple antibiotics such as ampicillin, ceftazidime and cefotaxime, were detected in V. parahaemolyticus (Lei et al., 2020). Additionally, a total of 12 resistance nodulation cell division (RND)-type efflux transporters playing important roles in intrinsic resistance to antibiotics were estimated in V. parahaemolyticus, among which VmeAB, VmeCD, VmeEF, VmeYZ have already been characterized (Matsuo et al., 2007, 2013). Majority of V. parahaemolyticus isolates are sensitivity to chloramphenicol (Amalina et al., 2019; Lei et al., 2020; Mok et al., 2021; Zaafrane et al., 2022). However, a novel chloramphenicol acetyltransferase gene, catC, is distributed among the V. parahaemolyticus strains, and heterologously expressing this gene was able to enhance chloramphenicol resistance of E. coli (Zhang et al., 2019).

The suicide plasmid pDS132 and the L-arabinose induced plasmid pBAD33 are widely used to construct specific mutants and complemented mutants, respectively (Guzman et al., 1995; Philippe et al., 2004). Both pDS132 and pBAD33 harbor a chloramphenicol resistance gene, but V. parahaemolyticus strains transformed with pDS132 or pBAD33 were still unable to grow in the conditions containing chloramphenicol higher than 5 μg/mL (Sun et al., 2014; Zhang et al., 2018, 2023b; Zhang Y. et al., 2023). Therefore, chloramphenicol probably has great effect on the growth and physiology of V. parahaemolyticus. In this work, we aimed to investigate the sublethal dose of chloramphenicol on the physiology of V. parahaemolyticus. Notably reductions in growth, motility, biofilm formation, c-di-GMP production, cytoxicity and adhesion activity were evident in the response to sublethal doses of chloramphenicol. Sublethal dose of chloramphenicol greatly affected the expression of 650 genes in V. parahaemolyticus, including the antibiotic resistance genes, major virulence genes, biofilm-associated genes and putative regulatory genes. This work helps us to understand how chloramphenicol effect on the physiology of V. parahaemolyticus.

Materials and methods

Growth conditions

Vibrio parahaemolyticus RIMD2210633, which was isolated from a diarrhea patient in 1996 (Makino et al., 2003) and kindly provided by Dr. Dongsheng Zhou from Beijing Institute of Microbiology and Epidemiology, was used throughout in this work. Approximately 20 μL glycerol stock of bacterial cells was inoculated into 5 mL 2.5% (w/v) Bacto heart infusion broth (HI broth; BD Bioscience, USA), followed by incubated at 37°C with shaking at 200 rpm for 12 h. The resultant cultures were diluted 50-fold into 5 mL of fresh HI broth for the second round of growth, which were grown to an OD600 value of 1.5. The resultant cultures were then diluted 1000-fold into 5 mL of fresh HI broth for a third round of growth, and were harvested at an OD600 value of approximately 1.5. When necessary, the medium was supplemented with different concentrations of chloramphenicol (0, 0.2, 0.3 or 0.4 μg/mL).

Growth inhibition assay

The second round of bacterial cell cultures was diluted 1000-fold into 10 mL HI broth containing 0, 0.2, 0.3 or 0.4 μg/mL chloramphenicol in a glass tube, and allowed to grow continuously at 37°C with shaking at 200 rpm. Three biological replicates were set for each concentration. The growth curves were created by monitoring the OD600 values of each culture at 1 h intervals.

Biofilm formation assay

Biofilm formation capacities of V. parahaemolyticus under different concentrations of chloramphenicol were assessed by the crystal violet (CV) staining method, which was performed similarly as previously described (Fang et al., 2013; Zhang et al., 2021). Briefly, the second round of bacterial cell cultures was diluted 50-fold into 2 mL Difco marine (M) broth 2,216 (M broth; BD Bioscience, USA) containing 0, 0.2 or 0.4 μg/mL chloramphenicol in a 24-well cell culture plate, and allowed to grow at 30°C with shaking at 150 rpm for 48 h. The surface-attached cells were washed gently three times with deionized water after removing the planktonic cells, incubated at 80°C for 15 min to fix the biofilm cells, and then stained with 3 mL of 0.1% CV for 30 min. The CV stained biofilm cells were washed for another three times with deionized water. The bound CV was dissolved with 20% acetic acid, and the OD570 values were measured as an index of CV staining.

Colony morphology

Colony morphology assay was performed similarly as previously described (Zhang et al., 2021). Briefly, the second round of bacterial cell cultures was diluted 50-fold into 2 mL M broth in a 24-well cell culture plate, and allowed to grow without shaking at 30°C for 48 h. The cell culture was mixed thoroughly, and then 2 μL of the culture was spotted onto a HI agar containing 0, 0.2 or 0.4 μg/mL chloramphenicol, followed by incubated at 30°C for 48 h.

Opaque (OP)-translucent (TR) colony phenotypes

The OP-TR colony phenotypes were detected as previously described (Zhang et al., 2023b). Briefly, a small amount of overnight cell culture in HI broth was streaked onto a HI plate containing 0, 0.2 or 0.4 μg/mL chloramphenicol, and then statically incubated at 37°C for 24 h.

Swimming motility

Swimming motility assay was performed as previously described (Wu et al., 2022). Briefly, 2 μL of the second round of bacterial cell culture were inoculated into a swimming plate [1% Oxoid tryptone, 2% NaCl (Merck, Germany), and 0.5% Difco Noble agar (BD Biosciences, USA)] containing 0, 0.2 or 0.4 μg/mL chloramphenicol. The swimming plate was statically incubated at 37°C. Starting from the 3rd hour after incubation, the diameter of swimming area was measured per hour until the 7th hour.

Swarming motility

Swarming motility assay was performed as previously described (Wu et al., 2022). Briefly, 2 μL of the second round of bacterial culture were spotted on a solid swarm plate [2.5% Bacto heart infusion, 1.5% NaCl (Merck), and 2.0% Difco noble agar (BD Bioscience)] containing 0, 0.2 or 0.4 μg/mL chloramphenicol. The diameters of swarming zones were measured at the 24th, 48th, and 72th hours after incubation statically at 37°C.

Intracellular c-di-GMP quantification

Intracellular c-di-GMP levels were measured as previously described (Wu et al., 2022). Briefly, the second round of bacterial culture was diluted 1000-fold into 5 mL of HI broth containing 0, 0.2 and 0.4 μg/mL chloramphenicol, respectively, and incubated at 37°C with shaking to an OD600 value of 1.5. Bacterial cells were harvested and resuspended in 2 mL ice-cold phosphate buffered saline (PBS), and then incubated at 100°C for 5 min, followed by sonicated for 15 min (power 100%, frequency 37 kHz) in an ice-water bath. The supernatant containing c-di-GMP was collected, and the pellet was resuspended in 2 mL ice-cold PBS and re-extracted for another two times. The intracellular c-di-GMP levels were determined with a c-di-GMP Enzyme-linked Immunosorbent Assay (ELISA) Kit (Mskbio, Beijing, China). In addition, total protein in the supernatant was also determined by a Pierce BCA Protein Assay kit (ThermoFisher Scientific, USA). Intracellular c-di-GMP levels were expressed as pmol/g protein.

Cytotoxicity assay

Cytotoxicity assay was performed as previously described (Sun et al., 2014). Briefly, the second round of bacterial culture was diluted 1000-fold into 5 mL of HI broth containing 0, 0.2 and 0.4 μg/mL chloramphenicol, respectively, and incubated at 37°C with shaking to an OD600 value of 1.5. Bacterial cells were harvested, washed and then serially diluted with the pre-warmed Dulbecco’s modified Eagle’s medium (DMEM) lacking phenol red for colony forming unit (CFU) measurement and infection. HeLa cells were infected with 106 CFU of bacteria for 3 h at a multiplicity of infection (MOI) of 2.5. The release of lactate dehydrogenase (LDH) was quantified with a CytoTox 96® Non-Radioactive Cytotoxicity Assay kit (Promega, USA) according to the manufacturer’s instructions.

Adhesion assay

Adhesion assay was performed similarly as previously described (Zhang et al., 2017). Briefly, HeLa cell monolayers were maintained in DMEM supplemented with 10% fetal bovine serum (FBS, Invitrogen) at 37°C with 5% CO2. The second round of bacterial culture was diluted 1,000-fold into 5 mL of HI broth containing 0, 0.2 and 0.4 μg/mL chloramphenicol, respectively, and incubated at 37°C with shaking to an OD600 value of 1.5. Bacterial cells were collected, washed, and then re-suspended in DMEM. The cell monolayers were infected at multiplicity of infection (MOI) of 1:10. Bacterial cells were also added to empty wells to determine the amount of input as the final total number of V. parahaemolyticus. After incubation for 90 min, the monolayers were washed thrice with PBS and lysed with 1% Triton X-100. The lysates and input bacteria were serially diluted 10-fold and counted on LB agar plates. Percent adherence was calculated as bacterial cells adhered/input bacterial cells.

RNA sequencing (RNA-seq)

The second round of bacterial culture was diluted 1000-fold into 5 mL of HI broth containing 0 and 0.2 μg/mL chloramphenicol, respectively, and incubated at 37°C with shaking to an OD600 value of 1.5. Bacterial cells were harvested, and total RNA was extracted using TRIzol Reagent (Invitrogen, USA). RNA concentrations were measured using a Nanodrop 2000, and RNA integrity was evaluated using the agarose gel electrophoresis (Wu et al., 2022). rRNA removal and mRNA enrichment were performed using an Illumina/Ribo-Zero™ rRNA Removal Kit (bacteria) (Illumina, USA). cDNA library construction and sequencing were performed on an Illumina Hiseq platform at the GENEWIZ Biotechnology Co. Ltd. (Suzhou, China). The significantly differentially expressed genes (DEGs) were analyzed using the DESeq2 (V1.6.3) software with at least 2-fold changes in the ratio of mRNA levels (test/reference) and a p value of <0.05.

Quantitative PCR (qPCR)

qPCR assays were performed similarly as previously described (Gao et al., 2011). Briefly, the second round of bacterial culture was diluted 1000-fold into 5 mL of HI broth containing 0 and 0.2 μg/mL chloramphenicol, respectively, and incubated at 37°C with shaking to an OD600 value of 1.5. Bacterial cells were harvested, and total RNA was extracted using TRIzol Reagent. cDNA was generated from 1 μg total RNA using a FastKing First Strand cDNA Synthesis Kit (Tiangen Biotech, China). The relative mRNA level of each target gene was determined using the classical 2−ΔΔCt method with the 16S rRNA gene as the internal control. Primers used in this work were synthesized by GENEWIZ Biotechnology Co. Ltd. (Suzhou, China). Primers used in this work (Table 1) were synthesized by GENEWIZ Biotechnology Co., Ltd. (Suzhou, China) based on the solid phase subphosphorylation, and purified using the C18 column desalt method.

Table 1

TargetPrimers (forward/reverse, 5′-3′)Size (bp)References
VP0228GCTGCTAGTTTCTTATGTTC/GTCCGATCAAACCAACAAGG191This study
VP0775ACAAGGCACTAGGCATCC/GACCATCTGTTCGGCTAAG180Lu et al. (2021)
VP0778CTCGTGCGGAATTTGCTGATG/GGTTGTTGGTGTAAATGCTTG132Lu et al. (2021)
VP1393GGTCAACCTACTGGTCAACG/TAGTGCTCTTGCTTGCCTTG161Zhang et al. (2017)
VP1467TTGGTATCAAAGCAGAGCACTC/CTAAGGACATCCATTGGCAAGG174This study
VP1667GGAATGGATTGGAATCGTC/CCACCGTCTTTTATTTTGC175Zhang et al. (2019)
VP1687TGCTCACCGTTGCCAAATAG/GCGACGCTTTCATGTATTGC113Zhang et al. (2019)
VP1698AAGAGGAGCACGATATGAG/AACTGTCCACCACACTTC152Zhang et al. (2016)
VP1768TGAATCTCAGGCCAACATGC/AAATTCGCCGTTATTGATACCG199This study
VP2111GTTATGTCGCTACTCCGCAGC/CGAAAACACCGCATCACCAAA107This study
VP2362ACCTAGCGTCAGACAAAGGC/TGAACTGGACCGAAAGACAGG118This study
VP2467TTACAACCAAGACGGCAC/CCTTCCCAGAAACCAACA159Zhang et al. (2023a)
VP2523GGCTGAGCTGCATTACCAAG/TCCCACCGTCGATAGAACTG167Zhang et al. (2023b)
VP2700AGCGTTGATGAATAAAGGGA/GAACAACTGACGAGAAAACA139This study
VPA0168GGTATCTGCGTCATCACTTC/TGCAAATAGCGCCACCAAAG163This study
VPA0202GCTTTACAACAACTACGTGG/GGTATCTGACAAAGTATCAC118This study
VPA0299TGCCAAACGACTGAACATGA/GAGGTAAGTTGTCTGCCAGT146This study
VPA0360TCGTTCTTTACCTACGCCTTA/TGCCAATAACACTCGATAGAGC176This study
VPA0556TGAAGCGGAATTTGTGCGTG/ATCTGGTGTTGTCGCCATGT154This study
VPA0602TATCACAGCAACAGCAAACC/GTTTGGCACGTATGGAGATT152This study
VPA0609GCACAGAACTTATCGAAAGCC/ATCAAAAGATCATTCGAGATCGC133This study
VPA0717CTATATTTAACCCAACCAGCC/GATCGAAGACTTCAGCCCCTA76This study
VPA1027TAAAGGTGAAGCGACAGCG/AATCATATAGGCGTGTTGC137Qiu et al. (2020)
VPA1191TCAGGATGTCACGGTAATCG/GCCTGAAATCTGTGCTGTGA97This study
VPA1346GCTGCTGCGAATGATATTGC/TCTGGCGGTTGTATCCTCTG150This study
VPA1370AATCCGCCAAGGTGTAAAGC/GTTGACGCTGATGGTAGTGG171This study
VPA1446GCCTGAAATCCTAATGCTC/AGTGTCAGAAGGTGTATCAAC181Zhang et al. (2021)
VPA1418GATTTAGTCGGCAACAACAC/ATCCCAGTTGTTTGTCGAGC123This study
VPA1683AGACCACTACGAAGAGCTAC/GTACTGGATCTTGCCGATTG118This study
cpsAGAGAGCGGCAACCTATATCG/CGCCACGCCAACAGTAATG194Zhang et al. (2023b)
cpsEGTCTCTTGGCGTGCTTATC/GAGCCGACTTTACCCATTTG154Zhang et al. (2023b)
16S rRNAGACACGGTCCAGACTCCTAC/GGTGCTTCTTCTGTCGCTAAC179Zhang et al. (2023b)

Primers used for qPCR in this study.

Experimental replicates and statistical methods

The growth curves, CV staining, c-di-GMP quantification, swarming, swimming, cytotoxicity and adhesion assays were performed at least three independent times with three biological replicates in each time, and the results were expressed as the mean ± standard deviation (SD). Paired Student’s t-tests were used to calculate statistical the significance with a p-value less than 0.05 considered significant. Colony morphology and OP-TR colony switching assays were performed at least three independent times.

Results

Chloramphenicol inhibited the growth of Vibrio parahaemolyticus

The growth curves of V. parahaemolyticus in HI broth supplemented with 0, 0.2, 0.3, and 0.4 μg/mL chloramphenicol were measured to investigate whether sublethal doses of chloramphenicol have some effects on the growth of the bacterium. As shown in Figure 1, the growth rates of V. parahaemolyticus in the presence of chloramphenicol were significantly slower than in the absence of chloramphenicol, and V. parahaemolyticus manifested slower and slower growth rates with the increasing of chloramphenicol. These results suggested that sublethal doses of chloramphenicol were able to inhibit the growth of V. parahaemolyticus.

Figure 1

Sublethal doses of chloramphenicol reduced the biofilm formation capacity of Vibrio parahaemolyticus

The effects of sublethal doses of chloramphenicol on the biofilm formation capacity of V. parahaemolyticus were assessed using the CV staining and colony morphology assays. As shown in Figure 2A, V. parahaemolyticus grown in the presence of sublethal doses of chloramphenicol exhibited significantly less normalized CV staining relative to that grown in the absence of chloramphenicol (p < 0.05), and the higher chloramphenicol concentration was added, the less normalized CV staining was detected. As further confirmed by the colony morphology (Figure 2B), the colonies of V. parahaemolyticus on the HI plate supplemented with 0.4 μg/mL of chloramphenicol were smooth, whereas those on other concentrations of chloramphenicol containing plates were wrinkly. However, the colonies of V. parahaemolyticus on the HI plate without chloramphenicol were much more wrinkled than those on the plate supplemented with 0.2 μg/mL of chloramphenicol (Figure 2B). These results suggested that chloramphenicol dose-dependently inhibited the biofilm formation capacity of V. parahaemolyticus.

Figure 2

Chloramphenicol did not affect the OP-TR colony variation of Vibrio parahaemolyticus

Vibrio parahaemolyticus naturally switches between OR and TP colony phenotypes based on whether capsular polysaccharide (CPS) production or not (Chen et al., 2010). In this study, the data showed that V. parahaemolyticus manifested the OP colony phenotype no matter whether the chloramphenicol presence or not (Figure 3), suggesting that sublethal doses of chloramphenicol did not affect the OP-TR colony variation of V. parahaemolyticus. However, the lawn of V. parahaemolyticus on the HI plate supplemented with 0.4 μg/mL of chloramphenicol seemed to be much drier than those under the other two conditions (Figure 3), which may be related to the growth inhibition of chloramphenicol (Figure 1).

Figure 3

Sublethal doses of chloramphenicol reduced the motor capacity of Vibrio parahaemolyticus

Effect of sublethal doses of chloramphenicol on the motor capacity of V. parahaemolyticus was investigated using the swimming and swarming assays. As shown in Figure 4, the swimming and swarming motility of V. parahaemolyticus were significantly decreased in the presence of sublethal doses of chloramphenicol relative to the conditions without chloramphenicol at all time points tested. Higher concentration of chloramphenicol was able to reduce more the motor ability of V. parahaemolyticus. These results suggested that chloramphenicol dose-dependently inhibited swimming and swarming motility of V. parahaemolyticus.

Figure 4

Sublethal doses of chloramphenicol inhibited the production of intracellular c-di-GMP

The intracellular c-di-GMP levels were investigated to assess whether sublethal doses of chloramphenicol affect the c-di-GMP pool of V. parahaemolyticus. As shown in Figure 5, the intracellular c-di-GMP levels of V. parahaemolyticus were remarkably reduced in the presence of sublethal doses of chloramphenicol, suggesting that sublethal doses of chloramphenicol was able to inhibit the synthesis of intracellular c-di-GMP in V. parahaemolyticus.

Figure 5

Sublethal doses of chloramphenicol reduced the adherence and cytotoxicity of Vibrio parahaemolyticus

Effect of sublethal doses of chloramphenicol on the adherence and cytotoxicity of V. parahaemolyticus was investigated using the following virulence-associated phenotypes. First, cytotoxicity against HeLa cells of V. parahaemolyticus grown in the presence or absence of chloramphenicol was investigated regarding to the release of LDH from cultured cells (Figure 6A). The cytotoxicity of V. parahaemolyticus grown in the conditions with chloramphenicol was significantly reduced relative to that grown in the condition without chloramphenicol, suggesting that chloramphenicol inhibited the cytotoxicity of V. parahaemolyticus against HeLa cells. Second, adhesion activity of V. parahaemolyticus to HeLa cells was investigated using the adhesion assay (Figure 6B). The results showed that sublethal doses of chloramphenicol were able to influence the adhesion of V. parahaemolyticus to HeLa cells in a dose-dependent manner, as that the adhesion rates of V. parahaemolyticus under the conditions of 0.2 and 0.4 μg/mL chloramphenicol were only approximately 30 and 20% of that under the condition without chloramphenicol, respectively. Taken together, these results suggested that sublethal doses of chloramphenicol inhibited the adherence and cytotoxicity of V. parahaemolyticus.

Figure 6

Sublethal dose of chloramphenicol affected global gene expression of Vibrio parahaemolyticus

The growth of V. parahaemolyticus was severely inhibited by 0.4 μg/mL chloramphenicol (Figure 1). Therefore, the gene expression profiles of V. parahaemolyticus grown in HI broth supplemented with 0.2 (test) chloramphenicol were compared with those grown in HI broth containing 0 μg/mL chloramphenicol (reference) by RNA-seq to investigate the cellular pathways involved in the response to the sublethal dose of chloramphenicol. As shown in Figure 7A, a total of 650 genes were significantly differentially expressed in the response to chloramphenicol stress, of these 354 were down-regulated and 296 were up-regulated. The enrichment of gene ontology (GO) term showed that the DEGs were involved in molecular function (13 GO terms, 62 DEGs), followed by biological process (11 GO terms, 70 DEGs) and cellular component (6 GO terms, 48 DEGs) (Figure 7B). The results of Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that 15, 163, 17, 56 and 62 DEGs were involved in organismal systems, metabolism, human diseases, environmental information processing and cellular processes, respectively (Figure 7C). The results of Cluster of Orthologous Groups of proteins (COG) enrichment showed that the DEGs were divided into 20 functional categories, and the 5 top pathways were function unknown, general function prediction only, energy production and conversion, cell motility and amino acid transport and metabolism (Figure 7D). The detailed information of DEGs was listed in Supplementary Table S1.

Figure 7

Selected DEGs of interest

A total of 6 genes associated with antibiotic resistance were significantly differentially expressed in the response of chloramphenicol (Table 2), of these 3 were downregulated (VP2167, VPA0520, and VPA1590) and 5 were upregulated (VP3019, VPA0168, VPA1190, VPA1191, and VPA1647). Five genes encoding GGDEF and/or EAL-domain proteins were significantly differentially expressed, including 2 downregulated genes (VP1768 and VPA0202) and 3 upregulated genes (VPA0360, VPA0556, and VPA0609). Additionally, 1 lateral flagellar gene (VPA1546), 43 polar flagellar genes, 1 CPS-related gene (VP0228), 6 scv genes (VP1458, VP1461, VP1463, VP1464, VP1466, and VP1467), and 5 MSHA genes (VP2699, VP2700, VP2701, VP2702, and VP2703), 28 T3SS1-associated genes including exsD, 5 T3SS2-associated genes (VPA1342, VPA1345, VPA1346, VPA1361, and VPA1370), 1 T6SS1-related gene (hcp1), and 13 T6SS2-related genes were remarkably downregulated in the presence of chloramphenicol (Table 2). In addition, at least 23 putative regulatory genes were significantly differentially expressed including 11 downregulated and 12 upregulated genes (Table 2). The DEGs also contained other of interest genes including 2 antioxidative genes (katE1 and ahpC1) and 12 outer membrane protein (OMP) encoding genes (Table 2).

Table 2

Locus_tagGene nameFoldChangeRegulationProduction
c-di-GMP
VP17680.4828DownEAL domain-containing protein
VPA02020.4460DownGGDEF domain-containing protein
VPA03603.7684UpGGDEF domain-containing protein
VPA05562.8669UpSensor domain-containing diguanylate cyclase
VPA06092.0915UpBifunctional diguanylate cyclase/phosphodiesterase
Lateral flagella
VPA02612.5467UpFlagellar export chaperone FlgN
VPA1546flhA0.4280DownFlagellar biosynthesis protein FlhA
Polar flagellum
VP0771flgM0.4615DownFlagellar biosynthesis anti-sigma factor FlgM
VP0775flgB0.2595DownFlagellar basal body rod protein FlgB
VP0776flgC0.1843DownFlagellar basal body rod protein FlgC
VP0777flgD0.2071DownFlagellar hook assembly protein FlgD
VP0778flgE0.1785DownFlagellar hook protein FlgE
VP0780flgF0.0626DownFlagellar basal body rod protein FlgF
VP0781flgG0.0759DownFlagellar basal-body rod protein FlgG
VP0782flgH0.1017DownFlagellar basal body L-ring protein FlgH
VP0783flgI0.1317DownFlagellar basal body P-ring protein FlgI
VP0784flgJ0.1504DownFlagellar assembly peptidoglycan hydrolase FlgJ
VP0785flgK0.0635DownFlagellar hook-associated protein FlgK
VP0786flgL0.0996DownFlagellar hook-associated protein FlgL
VP0788flaC0.0887DownFlagellin
VP0790flaD0.0345DownFlagellin
VP0791flaE0.2255DownFlagellin
VP2111motY0.1216DownOmpA family protein
VP2224orf30.4790DownDUF2802 domain-containing protein
VP2226orf20.2940DownChemotaxis protein CheW
VP2227orf10.3686DownParA family protein
VP2228cheB0.3924DownChemotaxis response regulator protein-glutamate methylesterase
VP2229cheA0.2926DownChemotaxis protein CheA
VP2230cheZ0.3762DownProtein phosphatase CheZ
VP2231cheY0.4371DownChemotaxis response regulator CheY
VP2232fliA0.3984DownRNA polymerase sigma factor FliA
VP2235flhA0.4259DownFlagellar biosynthesis protein FlhA
VP2236flhB0.4912DownFlagellar biosynthesis protein FlhB
VP2237fliR0.2783DownFlagellar type III secretion system protein FliR
VP2239fliP0.3496DownFlagellar type III secretion system pore protein FliP
VP2242fliM0.3481DownFlagellar motor switch protein FliM
VP2243fliL0.3906DownFlagellar basal body-associated protein FliL
VP2244fliK0.2561DownFlagellar hook-length control protein FliK
VP2245fliJ0.3063DownFlagella biosynthesis chaperone FliJ
VP2246fliI0.4777DownFlagellar protein export ATPase FliI
VP2247fliH0.4270DownFlagellar assembly protein FliH
VP2252flaL0.4478DownPAS domain-containing protein
VP2254fliS0.0792DownFlagellar export chaperone FliS
VP2255flaI0.0573DownFlagellar protein FliT
VP2256fliD0.0878DownFlagellar filament capping protein FliD
VP2257flaG0.0784DownFlagellar protein FlaG
VP2258flaA0.0673DownFlagellin
VP2259flaB0.0483DownFlagellin
VP2261flaF0.0411DownFlagellin
VP2811motX0.1480DownSel1 repeat family protein
Capsule polysaccharide
VP02280.4513DownOligosaccharide repeat unit polymerase
Scv exopolysaccharide
VP1458scvO0.2906DownSugar transferase
VP1461scvM0.3120DownGlycosyltransferase
VP1463scvK0.2733DownGlycosyltransferase
VP1464scvJ0.1752DownO-antigen ligase family protein
VP1466scvH0.3166DownGlycosyltransferase family 4 protein
VP1467scvG0.2408DownGlycosyltransferase
Type IV pilin
VP2523pilA3.4930UpPilin
VP2699mshF0.3401DownMSHA biogenesis protein MshF
VP2700mshG0.4121DownType II secretion system F family protein
VP2701mshE0.3945DownGspE/PulE family protein
VP2702mshN0.4795DownMSHA biogenesis protein MshN
VP2703mshM0.4555DownExeA family protein
T3SS1
VP1656vopD0.2107DownType III secretion system translocon subunit VopD
VP1657vopB0.1130DownType III secretion system translocon subunit VopB
VP1658vcrH0.3639DownSycD/LcrH family type III secretion system chaperone VcrH
VP1659vcrV0.2281DownType III secretion system needle tip protein VcrV
VP1660vcrG0.2617DownLcrG family type III secretion system chaperone VcrG
VP1661vcrR0.3482DownLcrR family type III secretion system chaperone VcrR
VP1662vcrD0.3107DownSctV family type III secretion system export apparatus subunit VcrD
VP1664vscX0.3616DownType III secretion system protein VscX
VP16660.2139DownTyeA family type III secretion system gatekeeper subunit
VP1667vopN0.2554DownSctW family type III secretion system gatekeeper subunit VopN
VP1668vscN0.3004DownSctN family type III secretion system ATPase VscN
VP1669vscO0.2882DownType III secretion system central stalk protein VscO
VP1670vscP0.3062DownType III secretion system needle length determinant VscP
VP1671vscQ0.1864DownSctQ family type III secretion system cytoplasmic ring protein VscQ
VP1672vscR0.2178DownSctR family type III secretion system export apparatus subunit VscR
VP1680vopQ0.1078DownType III secretion system effector VopQ
VP1682vecA0.0877DownCesT family type III secretion system chaperone VecA
VP1686vopS0.2719DownT3SS effector adenosine monophosphate-protein transferase VopS
VP16870.3800DownCesT family type III secretion system chaperone
VP1689vscK0.2189DownSctK family type III secretion system sorting platform protein VscK
VP1690vscJ0.3265DownSctJ family type III secretion inner membrane ring lipoprotein Vsc
VP1692vscH0.2758DownYopR family T3SS polymerization control protein VscH
VP1693vscG0.3504DownYscG family type III secretion system chaperone VscG
VP1694vscF0.2839DownType III secretion system needle filament protein VscF
VP1695vscD0.2477DownSctD family type III secretion system inner membrane ring subunit VscD
VP1696vscC0.2480DownSctC family type III secretion system outer membrane ring subunit VscC
VP1697vscB0.2263DownYscB family type III secretion system chaperone VscB
VP1698esxD0.4088DownType III secretion system regulon anti-activator ExsD
T3SS2
VPA13430.3765DownHypothetical protein
VPA13450.4713DownHypothetical protein
VPA1346vopA0.3708DownType III secretion system YopJ family effector VopA
VPA1361vopD20.3781DownType III secretion system translocator protein VopD2
VPA1370vopL0.4842DownType III secretion system effector VopL
T6SS1
VP1393hcp10.4922DownHcp family type VI secretion system effector
T6SS2
VPA1027hcp20.1952DownType VI secretion system tube protein Hcp
VPA1028tssH0.2916DownType VI secretion system ATPase TssH
VPA1029tssG0.3176DownType VI secretion system baseplate subunit TssG
VPA1030tssF0.2643DownType VI secretion system baseplate subunit TssF
VPA1031tssE0.2103DownType VI secretion system baseplate subunit TssE
VPA10320.1504DownProtein of avirulence locus
VPA1033tssC0.2006DownType VI secretion system contractile sheath large subunit
VPA1034tssC0.1369DownType VI secretion system contractile sheath large subunit
VPA1035tssB0.1730DownType VI secretion system contractile sheath small subunit
VPA1036tssA0.2603DownType VI secretion system protein TssA
VPA10370.2925DownProtein phosphatase 2C domain-containing protein
VPA1038tagF0.2788DownType VI secretion system-associated protein TagF
VPA1039tssM0.3321DownType VI secretion system membrane subunit TssM
Putative regulators
VP02432.0226UpTranscriptional regulator
VP0247rraA0.4376DownRibonuclease E activity regulator RraA
VP06243.1754UpLysR family transcriptional regulator
VP12294.0701UpTetR/AcrR family transcriptional regulator
VP13760.2983DownResponse regulator
VP16493.1477UpGntR family transcriptional regulator
VP19620.4521DownCrp/Fnr family transcriptional regulator
VP20090.4655DownResponse regulator transcription factor
VP23962.2575UpLacI family DNA-binding transcriptional regulator
VP24502.0423UpMarR family transcriptional regulator
VP26320.4270DownLacI family DNA-binding transcriptional regulator
VP27770.4493DownTranscriptional regulator
VPA00112.4106UpYebC/PmpR family DNA-binding transcriptional regulator
VPA00530.4913DownTetR/AcrR family transcriptional regulator
VPA02990.3864DownLysR family transcriptional regulator
VPA03582.3513UpHelix-turn-helix transcriptional regulator
VPA03594.0065UpHelix-turn-helix transcriptional regulator
VPA06020.3564DownLysR family transcriptional regulator
VPA07173.4322UpLysR family transcriptional regulator
VPA08040.4881DownXRE family transcriptional regulator
VPA11782.7744UpSugar-binding transcriptional regulator
VPA1446cpsQ3.9098UpHelix-turn-helix transcriptional regulator
VPA16360.3543DownHelix-turn-helix transcriptional regulator
Outer membrane protein
VP0760chiP0.2340DownChitoporin
VP08870.4823DownOuter membrane lipoprotein carrier protein LolA
VP10082.4345UpPorin
VP12182.2271UpMtrB/PioB family decaheme-associated outer membrane protein
VP13562.8495UpBamA/TamA family outer membrane protein
VP2176aqpZ2.8829UpAquaporin Z
VP2362ompK0.3768DownOuter membrane protein OmpK
VP23850.0051DownAquaporin
VP2467ompU0.1193DownPorin
VPA02420.3722DownPorin family protein
VPA0527ompN2.6928UpPorin
VPA08604.9090UpOuter membrane protein transport protein
Antibiotic resistance
VP30192.3726UpMultidrug effflux MFS transporter
VPA0168emrD2.1828UpMultidrug efflux MFS transporter EmrD
VPA05200.3885DownMultidrug effflux MFS transporter
VPA1190vmeZ2.1611UpMultidrug efflux RND transporter permease subunit VmeZ
VPA1191vmeY6.0915UpMultidrug efflux RND transporter periplasmic adaptor subunit VmeY
VPA16473.3176UpMultidrug effflux MFS transporter

Selected genes from the DEGs.

Validation of RNA-seq data by qPCR

A total of 26 DEGs were selected as the target genes (Table 2) to subject to the qPCR assays to validate the RNA-seq data. As shown in Figure 8, the results of qPCR for all the tested genes manifested consistent trends with the RNA-seq data (Table 2), confirming the reliability of RNA-seq data. In addition, the qPCR results demonstrated that transcriptional levels of cpsA and cpsE were also remarkably downregulated in response to the chloramphenicol stress.

Figure 8

Discussion

Chloramphenicol has potent inhibition on bacterial protein biosynthesis via binding to the 50S subunit of ribosome (Bale et al., 2023), and thus has a significant impact on gene expression, bacterial physiology and behaviors. Addition of chloramphenicol to culture media significantly inhibited the growth and respiration of Escherichia coli (Smirnova et al., 2023). The biofilm formation abilities of Klebsiella sp., Pseudomonas aeruginosa, Achromobacter sp., Klebsiella pneumoniae, and Bacillus pumilis were significantly decreased in the presence of chloramphenicol (Liaqat et al., 2009). Chloramphenicol down-regulated flagellar gene expression and swimming and swarming motility of Salmonella enterica serovar Typhimurium, but up-regulated genes involved in invasion, attachment, and intracellular survival (Brunelle et al., 2014, 2017). Transcriptome analysis revealed that chloramphenicol affects global gene expression in multiple bacterial species including such as Streptococcus pneumoniae (Ng et al., 2003), Staphylococcus equorum (Heo et al., 2022), Bacillus subtilis (Lin et al., 2005), Yersinia pestis (Qiu et al., 2006), Thermotoga maritima (Montero et al., 2007), Pseudomonas putida (Fernandez et al., 2012), Myxococcus xanthus (Yang et al., 2019), Enterococcus faecalis (Tatta et al., 2023), and Escherichia coli (Bie et al., 2023). The genes that showed altered expression in response to chloramphenicol are involved in multiple cellular pathways including metabolism, stress response, regulation, and protein biosynthesis.

In this study, the data showed that sublethal doses of chloramphenicol remarkably inhibited the growth rate, biofilm formation, motility, c-di-GMP biosynthesis, cytoxicity and adherence activity of V. parahaemolyticus (Figures 1–6). The RNA-seq data disclosed that sublethal dose of chloramphenicol strikingly affected the expression of 650 genes in V. parahaemolyticus, of these 296 were upregulated and 354 were downregulated (Figure 7; Table 2). Majority of virulence genes (T3SS1, T6SS2, etc.), polar flagellar genes and biofilm-associated genes (msh, scv., cps, etc.) were down-regulated by sublethal dose of chloramphenicol (Figure 7; Table 2). Therefore, the reduction in functional phenotypes of V. parahaemolyticus is likely due to growth defect and downregulation of related gene expression. In addition, the results in this study also suggested that sublethal dose of chloramphenicol could be used as an anti-biofilm or anti-virulence regent to combat with V. parahaemolyticus contamination. There are currently many studies exploring the anti-virulence and anti-biofilm strategies toward bacteria (Imchen et al., 2022; Law and Tan, 2022). Findings show that some substances including cationic surfactants such as benzalkonium chloride (Park and Yoon, 2023), chemicals such as Rhein (Folliero et al., 2022) and 2,6-Di-tert-butyl-4-methylphenol (Santhakumari et al., 2018), peptides such as MSI-I (Ye et al., 2021) and PV-Q5 (Dai et al., 2023), and traditional chinese medicine such as gingerol (Shukla et al., 2021) and Ulva fasciata (Qiao et al., 2021) possess anti-virulence and/or anti-biofilm activity. Compared to antibiotics such as chloramphenicol, these substances have obvious advantages, such as less susceptibility to bacterial resistance. Further research is needed to discover compounds with strong applicability that can reduce the virulence and biofilm formation capacity of V. parahaemolyticus.

Drug efflux from bacterial cells is one of the key mechanisms of drug resistance (Stephen et al., 2022). There are five major groups of drug efflux pumps, that is, the RND family, the MF (major facilitator) family, the MATE (multidrug and toxic compound extrusion) family, the SMR (small multidrug resistance) family and the ABC (ATP binding cassette) superfamily (Stephen et al., 2022). V. parahaemolyticus possesses 12 RND-type efflux pumps (Matsuo et al., 2013), but only VmeYZ was induced by the sublethal dose of chloramphenicol (Table 2), suggesting that VmeYZ may play the key role in the resistance of V. parahaemolyticus to chloramphenicol. Moreover, VP3019, emrD, VPA0520 and VPA1647 encoding the MF-type pumps (Makino et al., 2003) were also upregulated by the sublethal dose of chloramphenicol (Table 2), but their roles in V. parahaemolyticus remain ill-defined.

Reducing antibiotic influx through OMP channels is another important mechanism of drug resistance in bacteria (Rodrigues et al., 2022). For example, in E. coli, OmpC is associated with β-lactams resistance, OmpF with β-lactams and fluoroquinolone resistance, and TolC, YddB, OmpX and TosA with the resistances of enrofloxacin, novobiocin, fluoroquinolones, β-lactams and globomycin (Rodrigues et al., 2022). Seventeen OMPs including OmpU, OmpN, OmpA, OmpV and OmpK are associated with the resistance of V. alginolyticus to erythromycin, tetracycline, kanamycin, streptomycin, nalidixic acid and chloromycetin (Xiong et al., 2010). OmpN is involved in the indole-dependent tetracycline resistance of V. splendidus (Zhang et al., 2020). Twelve OMP genes were regulated by the sublethal dose of chloramphenicol including the known porins such as OmpU, OmpK and OmpN (Table 2), indicating that OMPs were remodeled in the response to the chloramphenicol. However, whether these putative OMPs are associated with chloramphenicol resistance of V. parahaemolyticus remains unknown.

Vibrio parahaemolyticus has a strong ability to form biofilms, which are also closely linked to the antibiotic resistance (Mishra et al., 2023). V. parahaemolyticus undergoes the phase variation between the wrinkly and smooth colony phenotypes, which is based on whether the EPS production or not (Wu et al., 2022). EPS production is associated with the cpsA-K and scvA-O gene clusters that positively correlate with the biofilm formation by V. parahaemolyticus, but the wrinkly colony phenotype is only attributed to the expression of cpsA-K (Liu et al., 2022). Sublethal doses of chloramphenicol inhibited V. parahaemolyticus to form the wrinkly colony and biofilms (Figure 2), but no transcripts of cps genes were detected by RNA-seq. By contrast, six scv genes were remarkably low expressed in the response to chloramphenicol (Table 2). However, the results of qPCR showed that the transcriptional levels of cpsA and cpsE were notably decreased in the response to chloramphenicol (Figure 8), suggesting that the undetectable of cps genes probably be caused by the preparation of RNA-seq samples.

One CPS gene, VP0228, was remarkably decreased in the presence of sublethal dose of chloramphenicol (Table 2). There are 25 genes in the CPS locus (VP0214-0238) (Okura et al., 2008), and only one of them was regulated, which was likely to have no impact on the synthesis of CPS. Indeed, CPS production was not affected by sublethal dose of chloramphenicol (Figure 3). V. parahaemolyticus expresses dual flagellar systems: a single polar flagellum for swimming in liquid and peritrichous lateral flagella for swarming over surface (McCarter, 2004). Strains with defective polar flagellum failed to form mature biofilms, which can be restored by exogenous addition of recombinant polar flagellins (Enos-Berlage et al., 2005; Jung et al., 2019). Although lacks detailed mechanisms, lateral flagella are thought to be required for the mature biofilm formation (Yildiz and Visick, 2009). A total of 43 polar flagellar genes were remarkably downregulated in the presence of sublethal dose of chloramphenicol (Table 2). However, only 2 lateral flagellar genes were significantly differentially expressed, of these 1 was upregulated and 1 was downregulated (Table 2). Therefore, the inhibitory effect of sublethal dose of chloramphenicol on swimming probably be mainly attributed to the downregulation of polar flagellar genes, whereas on swarming may be more related to the growth inhibition of V. parahaemolyticus. In addition, V. parahaemolyticus produces two kinds of type IV pili: MSHA and ChiRP (Makino et al., 2003). MSHA and ChiRP are required for the mature biofilm formation of V. parahaemolyticus (Shime-Hattori et al., 2006). The RNA-seq data showed that five MSHA genes were downregulated but one ChiRP gene was upregulated in the response to sublethal dose of chloramphenicol (Table 2), indicating that chloramphenicol-dependent biofilm inhibition was closely related to the different expression of type IV pili.

c-di-GMP, a ubiquitous second messenger, is involved in controlling multiple physiological roles of bacteria including motility, adherence, biofilm formation, virulence and cell cycle progression (Jenal et al., 2017). c-di-GMP is synthesized by guanylate cyclase (DGC) carrying a GGDEF domain, whereas is degraded by phosphodiesterase (PDF) carrying either a EAL or HD-GYP domain (Jenal et al., 2017). More than 50 proteins may be involved in the metabolism of c-di-GMP in V. parahaemolyticus (Seshasayee et al., 2010). However, only a small portion of them were demonstrated to be required for the c-di-GMP metabolism, including the GGDEF-EAL-containing proteins, ScrG and ScrC, the EAL-containing protein LafV, and the GGDEF-containing proteins, ScrO, GefA, ScrJ and ScrL (Kim and McCarter, 2007; Ferreira et al., 2008; Kimbrough et al., 2020; Kimbrough and McCarter, 2021; Zhong et al., 2022). In this study, a total of 5 genes probably encoding DGCs or PDFs were significantly differentially expressed in the stimulation of sublethal dose of chloramphenicol (Table 2), of these 2 (VP1768 and VPA0202) were downregulated and 3 (VPA0360, VPA0556 and VPA0609) were upregulated. The clarifying functions of these genes will be beneficial for us to understand the regulatory mechanisms of sublethal dose of chloramphenicol on c-di-GMP metabolism in V. parahaemolyticus.

The expression levels of 28 T3SS1 genes including exsD were remarkably decreased in the presence of sublethal dose of chloramphenicol (Table 2). Transcription of T3SS1 genes was positively regulates by ExsA (Zhou et al., 2008). ExsD binds ExsA to block the regulatory activity of ExsA and thereby inhibiting the expression of T3SS1 genes (Zhou et al., 2010). In addition, five T3SS2 genes, one T6SS1 gene and 13 T6SS2 genes were remarkably downregulated in the response to sublethal dose of chloramphenicol (Table 2). T3SS1 is mainly involved in cytotoxicity, whereas T3SS2 predominantly contributes to enterotoxicity, and both are required for the full virulence of V. parahaemolyticus (Park et al., 2004; Hiyoshi et al., 2010). By contrast, T6SS1 is required for the antibacterial activity of V. parahaemolyticus, whereas T6SS2 mainly acts as an adherence factor (Yu et al., 2012; Salomon et al., 2013). In brief, downregulating the major virulence genes may be beneficial for V. parahaemolyticus to combat the killing effect of chloramphenicol.

RNA-seq data also revealed that at least 23 genes encoding putative regulators were significantly differentially expressed in the response to sublethal dose of chloramphenicol, of these 11 were downregulated and 12 were upregulated (Table 2). Some genes encode global regulators, including LysR family transcriptional regulators (VP0624, VPA0299, VPA0602, and VPA0717), TetR/AcrR family transcriptional regulators (VP1229 and VPA0053), MarR family transcriptional regulator (VP2450) and GntR family transcriptional regulator (VP1649). In addition, the sublethal dose of chloramphenicol remarkably induced the expression of CpsQ, a c-di-GMP binding regulatory protein that promotes the expression of cpsA-K and biofilm formation by V. parahaemolyticus (Ferreira et al., 2012), suggesting that this regulator may also be required for resistance to chloramphenicol stress. However, the functions of the other regulatory genes are currently unknown, and future experiments should be designed to elucidate the roles of these regulators.

In conclusion, the present data demonstrated that the growth rate, biofilm formation capacity, c-di-GMP synthesis, motility, cytoxicity and adherence activity of V. parahaemolyticus were remarkably downregulated by the sublethal of chloramphenicol. A total of 650 genes were significantly differentially expressed in the response to chloramphenicol, including antibiotic resistance genes, major virulence genes, biofilm-associated genes and putative regulatory genes. Majority of genes involved in polar flagellum, EPS, MSHA, T3SS1, T3SS2 and T6SS2 were downregulated. In addition, five putative c-di-GMP metabolism genes were significantly differentially expressed, which may be the reason for the decrease in intracellular c-di-GMP levels in the response to chloramphenicol. Moreover, 23 putative regulatory genes were also significantly differentially expressed due to the stimulation of sublethal of chloramphenicol, suggesting that these regulators may be involved in the resistance of V. parahaemolyticus to chloramphenicol stress. This work helps us to understand how chloramphenicol effect on the physiology of V. parahaemolyticus. However, transcriptome analysis is only a preliminary study on the adaptation mechanism of V. parahaemolyticus to the sublethal dose of chloramphenicol, and more research should be performed to discover the underlying molecular mechanisms especially the regulation mechanisms involved in the resistance to chloramphenicol.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Research Projects of Nantong Health Commission (Grant No. QN2022044).

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Data availability statement

The raw data of RNA-seq are deposited in the NCBI repository (accession number PRJNA8742250).

Author contributions

MZ: Formal analysis, Investigation, Writing – original draft. LC: Formal analysis, Investigation, Writing – original draft. XiL: Investigation. XueL: Funding acquisition, Investigation. TZ: Investigation. FW: Investigation. YZ: Data curation, Formal analysis, Methodology, Supervision, Validation, Visualization, Writing – review & editing. RL: Methodology, Resources, Supervision, Validation, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2023.1275441/full#supplementary-material

References

  • 1

    AmalinaN. Z.SanthaS.ZulperiD.AmalM. N. A.YusofM. T.Zamri-SaadM.et al. (2019). Prevalence, antimicrobial susceptibility and plasmid profiling of vibrio spp. isolated from cultured groupers in peninsular Malaysia. BMC Microbiol.19:251. doi: 10.1186/s12866-019-1624-2

  • 2

    BaleB. I.ElebesunuE. E.ManikavasagarP.AgwunaF. O.OgunkolaI. O.SowA. U.et al. (2023). Antibiotic resistance in ocular bacterial infections: an integrative review of ophthalmic chloramphenicol. Trop. Med. Health51:15. doi: 10.1186/s41182-023-00496-x

  • 3

    BieL.ZhangM.WangJ.FangM.LiL.XuH.et al. (2023). Comparative analysis of transcriptomic response of Escherichia coli K-12 MG1655 to nine representative classes of antibiotics. Microbiol. Spectr.11:e0031723. doi: 10.1128/spectrum.00317-23

  • 4

    BrunelleB. W.BearsonB. L.BearsonS. M. (2014). Chloramphenicol and tetracycline decrease motility and increase invasion and attachment gene expression in specific isolates of multidrug-resistant Salmonella enterica serovar typhimurium. Front. Microbiol.5:801. doi: 10.3389/fmicb.2014.00801

  • 5

    BrunelleB. W.BearsonB. L.BearsonS. M. D.CaseyT. A. (2017). Multidrug-resistant Salmonella enterica Serovar typhimurium isolates are resistant to antibiotics that influence their swimming and swarming motility. mSphere2:e00306-17. doi: 10.1128/mSphere.00306-17

  • 6

    CaiQ.ZhangY. (2018). Structure, function and regulation of the thermostable direct hemolysin (TDH) in pandemic Vibrio parahaemolyticus. Microb. Pathog.123, 242–245. doi: 10.1016/j.micpath.2018.07.021

  • 7

    ChenY.DaiJ.MorrisJ. G.Jr.JohnsonJ. A. (2010). Genetic analysis of the capsule polysaccharide (K antigen) and exopolysaccharide genes in pandemic Vibrio parahaemolyticus O3:K6. BMC Microbiol.10:274. doi: 10.1186/1471-2180-10-274

  • 8

    ChenL.QiuY.TangH.HuL. F.YangW. H.ZhuX. J.et al. (2018). ToxR is required for biofilm formation and motility of Vibrio Parahaemolyticus. Biomed. Environ. Sci.31, 848–850. doi: 10.3967/bes2018.112

  • 9

    CoulthurstS. (2019). The type VI secretion system: a versatile bacterial weapon. Microbiology165, 503–515. doi: 10.1099/mic.0.000789

  • 10

    DaiJ.JinR.GaoJ.AweyaJ. J.LinR.LiG.et al. (2023). Antibacterial activity and mechanism of peptide PV-Q5 against Vibrio parahaemolyticus and Escherichia coli, derived from salt-fermented Penaeus vannamei. Foods12:12. doi: 10.3390/foods12091804

  • 11

    Enos-BerlageJ. L.GuvenerZ. T.KeenanC. E.McCarterL. L. (2005). Genetic determinants of biofilm development of opaque and translucent Vibrio parahaemolyticus. Mol. Microbiol.55, 1160–1182. doi: 10.1111/j.1365-2958.2004.04453.x

  • 12

    FangN.GaoH.WangL.QuS.ZhangY. Q.YangR. F.et al. (2013). Optimized methods for biofilm analysis in Yersinia pestis. Biomed. Environ. Sci.26, 408–411. doi: 10.3967/0895-3988.2013.05.012

  • 13

    FernandezM.CondeS.de la TorreJ.Molina-SantiagoC.RamosJ. L.DuqueE. (2012). Mechanisms of resistance to chloramphenicol in Pseudomonas putida KT2440. Antimicrob. Agents Chemother.56, 1001–1009. doi: 10.1128/AAC.05398-11

  • 14

    FerreiraR. B.AntunesL. C.GreenbergE. P.McCarterL. L. (2008). Vibrio parahaemolyticus ScrC modulates cyclic dimeric GMP regulation of gene expression relevant to growth on surfaces. J. Bacteriol.190, 851–860. doi: 10.1128/JB.01462-07

  • 15

    FerreiraR. B.ChodurD. M.AntunesL. C.TrimbleM. J.McCarterL. L. (2012). Output targets and transcriptional regulation by a cyclic dimeric GMP-responsive circuit in the Vibrio parahaemolyticus Scr network. J. Bacteriol.194, 914–924. doi: 10.1128/JB.05807-11

  • 16

    FollieroV.Dell’AnnunziataF.RoscettoE.AmatoA.GasparroR.ZannellaC.et al. (2022). Rhein: a novel antibacterial compound against Streptococcus mutans infection. Microbiol. Res.261:127062. doi: 10.1016/j.micres.2022.127062

  • 17

    GaoH.ZhangY.YangL.LiuX.GuoZ.TanY.et al. (2011). Regulatory effects of cAMP receptor protein (CRP) on porin genes and its own gene in Yersinia pestis. BMC Microbiol.11:40. doi: 10.1186/1471-2180-11-40

  • 18

    GuD.ZhangY.WangQ.ZhouX. (2020). S-nitrosylation-mediated activation of a histidine kinase represses the type 3 secretion system and promotes virulence of an enteric pathogen. Nat. Commun.11:5777. doi: 10.1038/s41467-020-19506-1

  • 19

    GuzmanL. M.BelinD.CarsonM. J.BeckwithJ. (1995). Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol.177, 4121–4130. doi: 10.1128/jb.177.14.4121-4130.1995

  • 20

    HeoS.KimT.NaH. E.LeeG.LeeJ. H.JeongD. W. (2022). Transcriptomic analysis of Staphylococcus equorum KM1031 from the high-salt fermented seafood jeotgal under chloramphenicol, erythromycin and lincomycin stresses. Sci. Rep.12:15541. doi: 10.1038/s41598-022-19897-9

  • 21

    HiyoshiH.KodamaT.IidaT.HondaT. (2010). Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity, and lethality in mice. Infect. Immun.78, 1772–1780. doi: 10.1128/IAI.01051-09

  • 22

    HuM.ZhangY.GuD.ChenX.WaldorM. K.ZhouX. (2021). Nucleolar c-Myc recruitment by a vibrio T3SS effector promotes host cell proliferation and bacterial virulence. EMBO J.40:e105699. doi: 10.15252/embj.2020105699

  • 23

    ImchenM.AnjuV. T.BusiS.MohanM. S.SubhaswarajP.DyavaiahM.et al. (2022). Metagenomic insights into taxonomic, functional diversity and inhibitors of microbial biofilms. Microbiol. Res.265:127207. doi: 10.1016/j.micres.2022.127207

  • 24

    JenalU.ReindersA.LoriC. (2017). Cyclic di-GMP: second messenger extraordinaire. Nat. Rev. Microbiol.15, 271–284. doi: 10.1038/nrmicro.2016.190

  • 25

    JungY. C.LeeM. A.LeeK. H. (2019). Role of Flagellin-homologous proteins in biofilm formation by pathogenic vibrio species. MBio10:10. doi: 10.1128/mBio.01793-19

  • 26

    KimY. K.McCarterL. L. (2007). ScrG, a GGDEF-EAL protein, participates in regulating swarming and sticking in Vibrio parahaemolyticus. J. Bacteriol.189, 4094–4107. doi: 10.1128/JB.01510-06

  • 27

    KimbroughJ. H.CribbsJ. T.McCarterL. L. (2020). Homologous c-di-GMP-binding Scr transcription factors orchestrate biofilm development in Vibrio parahaemolyticus. J. Bacteriol.202:e00723-19. doi: 10.1128/JB.00723-19

  • 28

    KimbroughJ. H.McCarterL. L. (2021). Identification of three new GGDEF and EAL domain-containing proteins participating in the Scr surface colonization regulatory network in Vibrio parahaemolyticus. J. Bacteriol.203:e00409-20. doi: 10.1128/JB.00409-20

  • 29

    LawS. K. K.TanH. S. (2022). The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies. Microbiol. Res.260:127032. doi: 10.1016/j.micres.2022.127032

  • 30

    LeiT.ZhangJ.JiangF.HeM.ZengH.ChenM.et al. (2020). Characterization of class 1 integrons harboring Bla(VEB-1) in Vibrio parahaemolyticus isolated from ready-to-eat foods in China. Int. J. Food Microbiol.318:108473. doi: 10.1016/j.ijfoodmicro.2019.108473

  • 31

    LiL.MengH.GuD.LiY.JiaM. (2019). Molecular mechanisms of Vibrio parahaemolyticus pathogenesis. Microbiol. Res.222, 43–51. doi: 10.1016/j.micres.2019.03.003

  • 32

    LiW.WangJ. J.QianH.TanL.ZhangZ.LiuH.et al. (2020). Insights into the role of extracellular DNA and extracellular proteins in biofilm formation of Vibrio parahaemolyticus. Front. Microbiol.11:813. doi: 10.3389/fmicb.2020.00813

  • 33

    LiaqatI.SumbalF.SabriA. N. (2009). Tetracycline and chloramphenicol efficiency against selected biofilm forming bacteria. Curr. Microbiol.59, 212–220. doi: 10.1007/s00284-009-9424-9

  • 34

    LinJ. T.ConnellyM. B.AmoloC.OtaniS.YaverD. S. (2005). Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Antimicrob. Agents Chemother.49, 1915–1926. doi: 10.1128/AAC.49.5.1915-1926.2005

  • 35

    LinI. T.TulmanE. R.GearyS. J.ZhouX. (2021). A gatekeeper protein contributes to T3SS2 function via interaction with an ATPase in Vibrio parahaemolyticus. Microbiol. Res.252:126857. doi: 10.1016/j.micres.2021.126857

  • 36

    LiuM.NieH.LuoX.YangS.ChenH.CaiP. (2022). A polysaccharide biosynthesis locus in Vibrio parahaemolyticus important for biofilm formation has homologs widely distributed in aquatic bacteria mainly from Gammaproteobacteria. mSystems7:e0122621. doi: 10.1128/msystems.01226-21

  • 37

    LiuM.ZhuX.ZhangC.ZhaoZ. (2021). LuxQ-LuxU-LuxO pathway regulates biofilm formation by Vibrio parahaemolyticus. Microbiol. Res.250:126791. doi: 10.1016/j.micres.2021.126791

  • 38

    LuR.SunJ.QiuY.ZhangM.XueX.LiX.et al. (2021). The quorum sensing regulator OpaR is a repressor of polar flagellum genes in Vibrio parahaemolyticus. J. Microbiol.59, 651–657. doi: 10.1007/s12275-021-0629-3

  • 39

    MakinoK.OshimaK.KurokawaK.YokoyamaK.UdaT.TagomoriK.et al. (2003). Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet361, 743–749. doi: 10.1016/S0140-6736(03)12659-1

  • 40

    MatsudaS.OkadaN.KodamaT.HondaT.IidaT. (2012). A cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H+-ATPase subunit c and ruptures host cell lysosomes. PLoS Pathog.8:e1002803. doi: 10.1371/journal.ppat.1002803

  • 41

    MatsuoT.HayashiK.MoritaY.KoterasawaM.OgawaW.MizushimaT.et al. (2007). VmeAB, an RND-type multidrug efflux transporter in Vibrio parahaemolyticus. Microbiology153, 4129–4137. doi: 10.1099/mic.0.2007/009597-0

  • 42

    MatsuoT.NakamuraK.KodamaT.MikamiT.HiyoshiH.TsuchiyaT.et al. (2013). Characterization of all RND-type multidrug efflux transporters in Vibrio parahaemolyticus. Microbiology2, 725–742. doi: 10.1002/mbo3.100

  • 43

    McCarterL. L. (2004). Dual flagellar systems enable motility under different circumstances. J. Mol. Microbiol. Biotechnol.7, 18–29. doi: 10.1159/000077866

  • 44

    MishraS.GuptaA.UpadhyeV.SinghS. C.SinhaR. P.HäderD. P. (2023). Therapeutic strategies against biofilm infections. Life13:172. doi: 10.3390/life13010172

  • 45

    MokJ. S.ChoS. R.ParkY. J.JoM. R.HaK. S.KimP. H.et al. (2021). Distribution and antimicrobial resistance of Vibrio parahaemolyticus isolated from fish and shrimp aquaculture farms along the Korean coast. Mar. Pollut. Bull.171:112785. doi: 10.1016/j.marpolbul.2021.112785

  • 46

    MonteroC. I.JohnsonM. R.ChouC. J.ConnersS. B.GeougeS. G.TachdjianS.et al. (2007). Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge. Appl. Environ. Microbiol.73, 5058–5065. doi: 10.1128/AEM.00453-07

  • 47

    NgW. L.KazmierczakK. M.RobertsonG. T.GilmourR.WinklerM. E. (2003). Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors. J. Bacteriol.185, 359–370. doi: 10.1128/JB.185.1.359-370.2003

  • 48

    OkuraM.OsawaR.TokunagaA.MoritaM.ArakawaE.WatanabeH. (2008). Genetic analyses of the putative O and K antigen gene clusters of pandemic Vibrio parahaemolyticus. Microbiol. Immunol.52, 251–264. doi: 10.1111/j.1348-0421.2008.00027.x

  • 49

    Osei-AdjeiG.HuangX.ZhangY. (2018). The extracellular proteases produced by Vibrio parahaemolyticus. World J. Microbiol. Biotechnol.34:68. doi: 10.1007/s11274-018-2453-4

  • 50

    PaisS. V.KimE.WagnerS. (2023). Virulence-associated type III secretion systems in gram-negative bacteria. Microbiology169:169. doi: 10.1099/mic.0.001328

  • 51

    ParkK. S.OnoT.RokudaM.JangM. H.IidaT.HondaT. (2004). Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus. Microbiol. Immunol.48, 313–318. doi: 10.1111/j.1348-0421.2004.tb03512.x

  • 52

    ParkS.YoonH. (2023). Transcriptional insight into the effect of benzalkonium chloride on resistance and virulence potential in Salmonella Typhimurium. Microbiol. Res.266:127240. doi: 10.1016/j.micres.2022.127240

  • 53

    PazhaniG. P.ChowdhuryG.RamamurthyT. (2021). Adaptations of Vibrio parahaemolyticus to stress during environmental survival, host colonization, and infection. Front. Microbiol.12:737299. doi: 10.3389/fmicb.2021.737299

  • 54

    PhilippeN.AlcarazJ. P.CoursangeE.GeiselmannJ.SchneiderD. (2004). Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid51, 246–255. doi: 10.1016/j.plasmid.2004.02.003

  • 55

    QiaoY.JiaR.LuoY.FengL. (2021). The inhibitory effect of Ulva fasciata on culturability, motility, and biofilm formation of Vibrio parahaemolyticus ATCC17802. Int. Microbiol.24, 301–310. doi: 10.1007/s10123-021-00165-1

  • 56

    QiuY.HuL.YangW.YinZ.ZhouD.YangH.et al. (2020). The type VI secretion system 2 of Vibrio parahaemolyticus is regulated by QsvR. Microb. Pathog.149:104579. doi: 10.1016/j.micpath.2020.104579

  • 57

    QiuJ.ZhouD.QinL.HanY.WangX.duZ.et al. (2006). Microarray expression profiling of Yersinia pestis in response to chloramphenicol. FEMS Microbiol. Lett.263, 26–31. doi: 10.1111/j.1574-6968.2006.00394.x

  • 58

    RaghunathP. (2014). Roles of thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) in Vibrio parahaemolyticus. Front. Microbiol.5:805. doi: 10.3389/fmicb.2014.00805

  • 59

    RodriguesI. C.RodriguesS. C.DuarteF. V.CostaP. M. D.CostaP. M. D. (2022). The role of outer membrane proteins in UPEC antimicrobial resistance: a systematic review. Membranes12:981. doi: 10.3390/membranes12100981

  • 60

    RuhalR.KatariaR. (2021). Biofilm patterns in gram-positive and gram-negative bacteria. Microbiol. Res.251:126829. doi: 10.1016/j.micres.2021.126829

  • 61

    SalomonD.GonzalezH.UpdegraffB. L.OrthK. (2013). Vibrio parahaemolyticus type VI secretion system 1 is activated in marine conditions to target bacteria, and is differentially regulated from system 2. PLoS One8:e61086. doi: 10.1371/journal.pone.0061086

  • 62

    SanthakumariS.JayakumarR.LogalakshmiR.PrabhuN. M.Abdul NazarA. K.Karutha PandianS.et al. (2018). In vitro and in vivo effect of 2,6-Di-tert-butyl-4-methylphenol as an antibiofilm agent against quorum sensing mediated biofilm formation of vibrio spp. Int. J. Food Microbiol.281, 60–71. doi: 10.1016/j.ijfoodmicro.2018.05.024

  • 63

    SeshasayeeA. S.FraserG. M.LuscombeN. M. (2010). Comparative genomics of cyclic-di-GMP signalling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res.38, 5970–5981. doi: 10.1093/nar/gkq382

  • 64

    Shime-HattoriA.IidaT.AritaM.ParkK. S.KodamaT.HondaT. (2006). Two type IV pili of Vibrio parahaemolyticus play different roles in biofilm formation. FEMS Microbiol. Lett.264, 89–97. doi: 10.1111/j.1574-6968.2006.00438.x

  • 65

    ShuklaA.ParmarP.PatelB.GoswamiD.SarafM. (2021). Breaking bad: better call gingerol for improving antibiotic susceptibility of Pseudomonas aeruginosa by inhibiting multiple quorum sensing pathways. Microbiol. Res.252:126863. doi: 10.1016/j.micres.2021.126863

  • 66

    SmirnovaG.TyulenevA.MuzykaN.UshakovV.SamoilovaZ.OktyabrskyO. (2023). Influence of growth medium composition on physiological responses of Escherichia coli to the action of chloramphenicol and ciprofloxacin. BioTech12:12. doi: 10.3390/biotech12020043

  • 67

    StephenJ.LekshmiM.AmminiP.KumarS. H.VarelaM. F. (2022). Membrane efflux pumps of pathogenic vibrio species: role in antimicrobial resistance and virulence. Microorganisms10:382. doi: 10.3390/microorganisms10020382

  • 68

    SunJ.LiX.HuZ.XueX.ZhangM.WuQ.et al. (2022). Characterization of Vibrio parahaemolyticus isolated from stool specimens of diarrhea patients in Nantong, Jiangsu, China during 2018-2020. PLoS One17:e0273700. doi: 10.1371/journal.pone.0273700

  • 69

    SunF.ZhangY.QiuY.YangH.YangW.YinZ.et al. (2014). H-NS is a repressor of major virulence gene loci in Vibrio parahaemolyticus. Front. Microbiol.5:675. doi: 10.3389/fmicb.2014.00675

  • 70

    TamayoR.PrattJ. T.CamilliA. (2007). Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol.61, 131–148. doi: 10.1146/annurev.micro.61.080706.093426

  • 71

    TattaE. R.PaulS.KumavathR. (2023). Transcriptome analysis revealed the synergism of novel rhodethrin inhibition on biofilm architecture, antibiotic resistance and quorum sensing Inenterococcus faecalis. Gene871:147436. doi: 10.1016/j.gene.2023.147436

  • 72

    WangL.LingY.JiangH.QiuY.QiuJ.ChenH.et al. (2013). AphA is required for biofilm formation, motility, and virulence in pandemic Vibrio parahaemolyticus. Int. J. Food Microbiol.160, 245–251. doi: 10.1016/j.ijfoodmicro.2012.11.004

  • 73

    WuQ.LiX.ZhangT.ZhangM.XueX.YangW.et al. (2022). Transcriptomic analysis of Vibrio parahaemolyticus underlying the wrinkly and smooth phenotypes. Microbiol. Spectr.10:e0218822. doi: 10.1128/spectrum.02188-22

  • 74

    XiongX. P.WangC.YeM. Z.YangT. C.PengX. X.LiH. (2010). Differentially expressed outer membrane proteins of Vibrio alginolyticus in response to six types of antibiotics. Mar. Biotechnol. (N.Y.)12, 686–695. doi: 10.1007/s10126-009-9256-4

  • 75

    XuM.YamamotoK.HondaT.MingX. (1994). Construction and characterization of an isogenic mutant of Vibrio parahaemolyticus having a deletion in the thermostable direct hemolysin-related hemolysin gene (trh). J. Bacteriol.176, 4757–4760. doi: 10.1128/jb.176.15.4757-4760.1994

  • 76

    XueX. F.ZhnagM. M.SunJ. F.LiX.WuQ. M.YinZ.et al. (2022). H-NS represses biofilm formation and c-di-GMP synthesis in Vibrio parahaemolyticus. Biomed. Environ. Sci.35, 821–829. doi: 10.3967/bes2022.106

  • 77

    YangY. J.SinghR. P.LanX.ZhangC. S.ShengD. H.LiY. Q. (2019). Whole transcriptome analysis and gene deletion to understand the chloramphenicol resistance mechanism and develop a screening method for homologous recombination in Myxococcus xanthus. Microb. Cell Factories18:123. doi: 10.1186/s12934-019-1172-3

  • 78

    YeX.HuangY.ZhouC.LiuX.ZhaoW.ZhaoX.et al. (2021). MSI-1 combats drug-resistant S. aureus by affecting bacterial viability and inhibiting carotenoid pigment production. Microbiol. Res.255:126909. doi: 10.1016/j.micres.2021.126909

  • 79

    YildizF. H.VisickK. L. (2009). Vibrio biofilms: so much the same yet so different. Trends Microbiol.17, 109–118. doi: 10.1016/j.tim.2008.12.004

  • 80

    YuY.YangH.LiJ.ZhangP.WuB.ZhuB.et al. (2012). Putative type VI secretion systems of Vibrio parahaemolyticus contribute to adhesion to cultured cell monolayers. Arch. Microbiol.194, 827–835. doi: 10.1007/s00203-012-0816-z

  • 81

    ZaafraneS.MaatoukK.AlibiS.BenM. H. (2022). Occurrence and antibiotic resistance of Vibrio parahaemolyticus isolated from the Tunisian coastal seawater. J. Water Health20, 369–384. doi: 10.2166/wh.2022.243

  • 82

    ZhangY.GaoH.Osei-AdjeiG.ZhangY.YangW.YangH.et al. (2017). Transcriptional regulation of the type VI secretion system 1 genes by quorum sensing and ToxR in Vibrio parahaemolyticus. Front. Microbiol.8:2005. doi: 10.3389/fmicb.2017.02005

  • 83

    ZhangY.HuL.Osei-AdjeiG.ZhangY.YangW.YinZ.et al. (2018). Autoregulation of ToxR and its regulatory actions on major virulence gene loci in Vibrio parahaemolyticus. Front. Cell. Infect. Microbiol.8:291. doi: 10.3389/fcimb.2018.00291

  • 84

    ZhangY.HuL.QiuY.Osei-AdjeiG.TangH.ZhangY.et al. (2019). QsvR integrates into quorum sensing circuit to control Vibrio parahaemolyticus virulence. Environ. Microbiol.21, 1054–1067. doi: 10.1111/1462-2920.14524

  • 85

    ZhangM.LuoX.LiX.ZhangT.WuF.LiM.et al. (2023a). L-arabinose affects the growth, biofilm formation, motility, c-di-GMP metabolism, and global gene expression of Vibrio parahaemolyticus. J. Bacteriol.e0010023. doi: 10.1128/jb.00100-23. [Epub ahead of print].

  • 86

    ZhangY.Osei-AdjeiG.NiB.FangH.ZhangL.ZhaoX.et al. (2016). Transcription of exsD is repressed directly by H-NS in Vibrio parahaemolyticus. Microb. Pathog.97, 221–225. doi: 10.1016/j.micpath.2016.06.003

  • 87

    ZhangL.Osei-AdjeiG.ZhangY.GaoH.YangW.ZhouD.et al. (2017). CalR is required for the expression of T6SS2 and the adhesion of Vibrio parahaemolyticus to HeLa cells. Arch. Microbiol.199, 931–938. doi: 10.1007/s00203-017-1361-6

  • 88

    ZhangY.QiuY.GaoH.SunJ.LiX.ZhangM.et al. (2021). OpaR controls the metabolism of c-di-GMP in Vibrio parahaemolyticus. Front. Microbiol.12:676436. doi: 10.3389/fmicb.2021.676436

  • 89

    ZhangY.QiuY.XueX.ZhangM.SunJ.LiX.et al. (2021). Transcriptional regulation of the virulence genes and the biofilm formation associated operons in Vibrio parahaemolyticus. Gut Pathog13:15. doi: 10.1186/s13099-021-00410-y

  • 90

    ZhangS.ShaoY.ZhaoX.LiC.GuoM.LvZ.et al. (2020). Indole contributes to tetracycline resistance via the outer membrane protein OmpN in Vibrio splendidus. World J. Microbiol. Biotechnol.36:36. doi: 10.1007/s11274-020-02813-6

  • 91

    ZhangG.SunK.AiG.LiJ.TangN.SongY.et al. (2019). A novel family of intrinsic chloramphenicol acetyltransferase CATC in Vibrio parahaemolyticus: naturally occurring variants reveal diverse resistance levels against chloramphenicol. Int. J. Antimicrob. Agents54, 75–79. doi: 10.1016/j.ijantimicag.2019.03.012

  • 92

    ZhangL.WengY.WuY.WangX.YinZ.YangH.et al. (2018). H-NS is an activator of exopolysaccharide biosynthesis genes transcription in Vibrio parahaemolyticus. Microb. Pathog.116, 164–167. doi: 10.1016/j.micpath.2018.01.025

  • 93

    ZhangM.XueX.LiX.WuQ.ZhangT.YangW.et al. (2023b). QsvR and OpaR coordinately repress biofilm formation by Vibrio parahaemolyticus. Front. Microbiol.14:1079653. doi: 10.3389/fmicb.2023.1079653

  • 94

    ZhangY.XueX.SunF.LiX.ZhangM.WuQ.et al. (2023). Quorum sensing and QsvR tightly control the transcription of vpa0607 encoding an active RNase II-type protein in Vibrio parahaemolyticus. Front. Microbiol.14:1123524. doi: 10.3389/fmicb.2023.1123524

  • 95

    ZhongX.LuZ.WangF.YaoN.ShiM.YangM. (2022). Characterization of GefA, a GGEEF domain-containing protein that modulates Vibrio parahaemolyticus motility, biofilm formation, and virulence. Appl. Environ. Microbiol.88:e0223921. doi: 10.1128/aem.02239-21

  • 96

    ZhouX.GewurzB. E.RitchieJ. M.TakasakiK.GreenfeldH.KieffE.et al. (2013). A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Rep.3, 1690–1702. doi: 10.1016/j.celrep.2013.03.039

  • 97

    ZhouX.KonkelM. E.CallD. R. (2010). Regulation of type III secretion system 1 gene expression in Vibrio parahaemolyticus is dependent on interactions between ExsA, ExsC, and ExsD. Virulence1, 260–272. doi: 10.4161/viru.1.4.12318

  • 98

    ZhouX.ShahD. H.KonkelM. E.CallD. R. (2008). Type III secretion system 1 genes in Vibrio parahaemolyticus are positively regulated by ExsA and negatively regulated by ExsD. Mol. Microbiol.69, 747–764. doi: 10.1111/j.1365-2958.2008.06326.x

Summary

Keywords

Vibrio parahaemolyticus, chloramphenicol, gene expression, biofilm, virulence

Citation

Zhang M, Cai L, Luo X, Li X, Zhang T, Wu F, Zhang Y and Lu R (2023) Effect of sublethal dose of chloramphenicol on biofilm formation and virulence in Vibrio parahaemolyticus. Front. Microbiol. 14:1275441. doi: 10.3389/fmicb.2023.1275441

Received

10 August 2023

Accepted

08 September 2023

Published

26 September 2023

Volume

14 - 2023

Edited by

Nidia León-Sicairos, Autonomous University of Sinaloa, Mexico

Reviewed by

Xiaohui Zhou, Southern University of Science and Technology, China; Uriel Alberto Angulo-Zamudio, Autonomous University of Sinaloa, Mexico

Updates

Copyright

*Correspondence: Yiquan Zhang, ; Renfei Lu,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics